Mesenchymal stem cells to treat type 1 diabetes

被引：31
|
作者：
Pixley, John S. [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Med, Div Rheumatol Immunol, 3601 4th St,MS 9410, Lubbock, TX 79430 USA
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2020年 / 1866卷 / 04期
关键词：
Stem cells; Mesenchymal stem cells; Type; 1; diabetes; BONE-MARROW DIFFERENTIATE; UMBILICAL-CORD; STROMAL CELLS; BETA-CELLS; IN-VITRO; ISLET TRANSPLANTATION; AUTOIMMUNE-DISEASES; INSULIN PRODUCTION; HUMAN HEPATOCYTES; CELLULAR-THERAPY;
D O I：
10.1016/j.bbadis.2018.10.033
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
What is clear is we are in the era of the stem cell and its potential in ameliorating human disease. Our perspective is generated from an in vivo model in a large animal that offers significant advantages (complete transplantation tolerance, large size and long life span). This review is an effort to meld our preclinical observations with others for the reader and to outline potential avenues to improve the present outlook for patients with diabetes. This effort exams the history or background of stem cell research in the laboratory and the clinic, types of stem cells, pluripotency or lack thereof based on a variety of pre-clinical investigations attempting endocrine pancreas recovery using stem cell transplantation. The focus is on the use of hematopoietic and mesenchymal stem cells. This review will also examine recent clinical experience following stem cell transplantation in patients with type 1 diabetes.
引用
收藏
页数：16
相关论文
共 50 条
  • [41] Mesenchymal Stromal Cells to Halt the Progression of Type 1 Diabetes?
    Per-Ola Carlsson
    Olle Korsgren
    Katarina Le Blanc
    Current Diabetes Reports, 2015, 15
  • [42] Placenta derived Mesenchymal Stem Cells transplantation in Type 1 diabetes: preliminary report of phase 1 clinical trial
    Sedighegh Madani
    Aria Setudeh
    Hamid Reza Aghayan
    Sepideh Alavi-Moghadam
    Mahtab Rouhifard
    Negar Rezaei
    Parastoo Rostami
    Reihaneh Mohsenipour
    Davoud Amirkashani
    Fatemeh Bandarian
    Babak Arjmand
    Bagher Larijani
    Journal of Diabetes & Metabolic Disorders, 2021, 20 : 1179 - 1189
  • [43] Placenta derived Mesenchymal Stem Cells transplantation in Type 1 diabetes: preliminary report of phase 1 clinical trial
    Madani, Sedighegh
    Setudeh, Aria
    Aghayan, Hamid Reza
    Alavi-Moghadam, Sepideh
    Rouhifard, Mahtab
    Rezaei, Negar
    Rostami, Parastoo
    Mohsenipour, Reihaneh
    Amirkashani, Davoud
    Bandarian, Fatemeh
    Arjmand, Babak
    Larijani, Bagher
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2021, 20 (02) : 1179 - 1189
  • [44] Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells
    Paeth, Guenter
    Perakakis, Nikolaos
    Mantzoros, Christos S.
    Seufert, Jochen
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 90 : 1 - 15
  • [45] Immunological Applications of Stem Cells in Type 1 Diabetes
    Fiorina, Paolo
    Voltarelli, Julio
    Zavazava, Nicholas
    ENDOCRINE REVIEWS, 2011, 32 (06) : 725 - 754
  • [46] Type 1 Diabetes Treatments Based on Stem Cells
    Arana, Miriam
    Kumar, Anujith
    Ashwathnarayan, Ashwini
    Atari, Maher
    Barajas, Miguel
    CURRENT DIABETES REVIEWS, 2018, 14 (01) : 14 - 23
  • [47] Stem cells may help type 1 diabetes
    Wilson, Clare
    NEW SCIENTIST, 2023, 246 (3442) : 14 - 14
  • [48] The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses
    MacDonald, Elizabeth S.
    Barrett, Jennifer G.
    FRONTIERS IN VETERINARY SCIENCE, 2020, 6
  • [49] Concise Review: Mesenchymal Stem Cells for Diabetes
    Dominguez-Bendala, Juan
    Lanzoni, Giacomo
    Inverardi, Luca
    Ricordi, Camillo
    STEM CELLS TRANSLATIONAL MEDICINE, 2012, 1 (01) : 59 - 63
  • [50] The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
    Napoli, Nicola
    Strollo, Rocky
    Paladini, Angela
    Briganti, Silvia I.
    Pozzilli, Paolo
    Epstein, Sol
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
12345